Cargando…
Incretin hormones and type 2 diabetes
Incretin hormones (glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1]) play a role in the pathophysiology of type 2 diabetes. Along with their derivatives they have shown therapeutic success in type 2 diabetes, with the potential for further improvements in glycae...
Autores principales: | Nauck, Michael A., Müller, Timo D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474001/ https://www.ncbi.nlm.nih.gov/pubmed/37430117 http://dx.doi.org/10.1007/s00125-023-05956-x |
Ejemplares similares
-
Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
por: Boer, Geke Aline, et al.
Publicado: (2020) -
Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity
por: Marrano, Nicola, et al.
Publicado: (2021) -
Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
por: Rosenberg, Jared, et al.
Publicado: (2021) -
Insulin clearance and incretin hormones following oral and “isoglycemic” intravenous glucose in type 2 diabetes patients under different antidiabetic treatments
por: Tura, Andrea, et al.
Publicado: (2022) -
Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
por: Meier, Juris J., et al.
Publicado: (2010)